1,147
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Effectiveness of primary series, first, and second booster vaccination of monovalent mRNA COVID-19 vaccines against symptomatic SARS-CoV-2 infections and severe diseases during the SARS-CoV-2 omicron BA.5 epidemic in Japan: vaccine effectiveness real-time surveillance for SARS-CoV-2 (VERSUS)

, , , , , , , , , , , , , , , , , , , , , , , , , , , , , , & show all
Pages 213-225 | Received 11 Dec 2023, Accepted 23 Jan 2024, Published online: 08 Feb 2024